Using Nutrigenomics to Evaluate Apoptosis as a Preemptive Target in Cancer Prevention

E-ISSN： 1873-5576|7|5|438-446

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.5, 2007-08, pp. : 438-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nutrigenomics and the prevention of colon cancer

By Davis Cindy D

Pharmacogenomics, Vol. 8, Iss. 2, 2007-02 ,pp. : 121-124

Future Medicine

Access to resources Recommend Favorite

AP-1 a Target for Cancer Prevention

Current Cancer Drug Targets, Vol. 7, Iss. 4, 2007-06 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer

By Crosby Colin G DuBois Raymond N

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

The centrosome as potential target for cancer therapy and prevention

By Korzeniewski Nina Hohenfellner Markus Duensing Stefan

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 43-52

Informa Healthcare

Access to resources Recommend Favorite

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

By Subbaramaiah K. Dannenberg A.J.

Trends in Pharmacological Sciences, Vol. 24, Iss. 2, 2003-02 ,pp. : 96-102

Elsevier

Access to resources Recommend Favorite